# Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

> **NCT05064956** · PHASE2 · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 26 (actual)

## Conditions studied

- Ebola Virus Disease
- Ebola
- Hiv

## Interventions

- **BIOLOGICAL:** Ad26.ZEBOV

## Key facts

- **NCT ID:** NCT05064956
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-06
- **Primary completion:** 2021-11-17
- **Final completion:** 2022-10-24
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064956, "Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05064956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*